Log in to save to my catalogue

Urinary neutrophil gelatinase‐associated lipocalin: A novel biomarker for predicting chronic kidney...

Urinary neutrophil gelatinase‐associated lipocalin: A novel biomarker for predicting chronic kidney...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_abfec322a55146f48ad7402e8be4da45

Urinary neutrophil gelatinase‐associated lipocalin: A novel biomarker for predicting chronic kidney disease in patients with nonalcoholic fatty liver disease

About this item

Full title

Urinary neutrophil gelatinase‐associated lipocalin: A novel biomarker for predicting chronic kidney disease in patients with nonalcoholic fatty liver disease

Publisher

Nanjing: John Wiley & Sons, Inc

Journal title

Portal hypertension & cirrhosis (Print), 2022-12, Vol.1 (3), p.157-166

Language

English

Formats

Publication information

Publisher

Nanjing: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims
Nonalcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are common diseases worldwide. Reports of a high prevalence of CKD in NAFLD patients have been documented. Urinary neutrophil gelatinase‐associated lipocalin (NGAL) is a reliable biomarker for renal dysfunction, and it is recommended for early detection of acute kidne...

Alternative Titles

Full title

Urinary neutrophil gelatinase‐associated lipocalin: A novel biomarker for predicting chronic kidney disease in patients with nonalcoholic fatty liver disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_abfec322a55146f48ad7402e8be4da45

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_abfec322a55146f48ad7402e8be4da45

Other Identifiers

ISSN

2770-5846,2770-5838

E-ISSN

2770-5846

DOI

10.1002/poh2.32

How to access this item